Presenting Monogenic Heart Failure Disease Modeling in Kyoto

https://www.termis.org/wc2018/

On September 7th, CSO speaks about monogenic disease modeling using NuHeart™ technology during TERM for heart, blood vessel & lung session.

99-O-5: Personalized micro-3D human heart 
tissues for orphan drug development
Tetsuro Wakatsuki,Neil Daily,Pinar Kemanli,
Michael Greenberg,Jennifer Strande
InvivoSciences, Inc. Madison Wisconsin, USA, Washington University, St. Louis, Medical College of Wisconsin.

Contract Research Organization for Drug Discovery